Question 1

What factors should I consider when comparing Nippon India Pharma Fund - Direct (G) vs SBI Equity Hybrid Fund - Direct (G)?

Accepted Answer

When comparing Nippon India Pharma Fund - Direct (G) vs SBI Equity Hybrid Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.

Question 2

Can I invest in Nippon India Pharma Fund - Direct (G) and SBI Equity Hybrid Fund - Direct (G) simultaneously?

Accepted Answer

Yes, you can invest in both Nippon India Pharma Fund - Direct (G) and SBI Equity Hybrid Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.

Question 3

What does the portfolio turnover ratio tell us when comparing Nippon India Pharma Fund - Direct (G) and SBI Equity Hybrid Fund - Direct (G)?

Accepted Answer

While comparing Nippon India Pharma Fund - Direct (G) and SBI Equity Hybrid Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.

Question 4

Can I switch between Nippon India Pharma Fund - Direct (G) and SBI Equity Hybrid Fund - Direct (G) if needed?

Accepted Answer

Yes, you can typically switch between Nippon India Pharma Fund - Direct (G) and SBI Equity Hybrid Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.

Question 5

Can I compare Nippon India Pharma Fund - Direct (G) and SBI Equity Hybrid Fund - Direct (G) based on their dividend payout?

Accepted Answer

Yes, you can compare Nippon India Pharma Fund - Direct (G) and SBI Equity Hybrid Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Nippon India Pharma Fund - Direct (G) vs SBI Equity Hybrid Fund - Direct (G)

Nippon India Pharma Fund - Direct (G)

7.4%

SBI Equity Hybrid Fund - Direct (G)

5.13%

About Fund

Fund Details

Get your FAQs right